FBT
IONS icon

First Bank & Trust’s Ionis Pharmaceuticals IONS Stock Holding History

First Bank & Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15
Closed -$1K – 334
2022
Q2 		$1K Hold
15
– – ﹤0.01% 472
2022
Q1 		$1K Hold
15
– – ﹤0.01% 497
2021
Q4 		$0 Buy
+15
New +$472 ﹤0.01% 520

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Bank & Trust's IONS Position: Q3 2022 in Review

First Bank & Trust sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 15 shares — an estimated $1K sold.

First Bank & Trust first reported a position in IONS in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • First Bank & Trust reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • First Bank & Trust sold 15 Ionis Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • First Bank & Trust first reported a position in Ionis Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • First Bank & Trust's Ionis Pharmaceuticals position peaked at $1K in Q2 2022.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.